Kent E. Pryor

Kent E. Pryor has been the CEO and Director of ZZ Biotech since April 2010. Prior to that, they served as the Chief Operating Officer of SynthRx Inc from May 2008 to April 2010. Kent has also been an Advisory Board Member of Assay Depot since February 2008, and was previously the Associate Director of Drug Development at Kemia, Inc. from June 2002 to April 2008. Kent has also been a Scientific Advisory Board Member of Bioatrix Pty Ltd from April 2014 to December 2015, and a Group Leader of Medicinal Chemistry at Corvas International, Inc. from July 1999 to June 2002.

Kent E. Pryor has an MBA from the University of California, San Diego - Rady School of Management, a PhD in Organic Chemistry from the Massachusetts Institute of Technology, and a BA in Chemistry from Rice University.

Some individuals on their team include Susan Willingham - Director, Finance, Craig Van De Mark - Director & VP, Legal, and Howard Levy - Senior Medical Advisor.